Quantitative analysis of the inverse correlation between CRELD2 and FASN revealed a significantly higher CRELD2 to FASN ratio in healthy participants compared to those with NASH patients (Figure 8A and Figure S8). This evidence concerns the gene CRELD2 and metabolic dysfunction-associated steatohepatitis.